Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome

Dong-Hyeon LEE; Hui-Kyung JEON; Ji-Han YOU; Mi-Yeon PARK; Seung-Jae LEE; Sung-Sik KIM; Byung-Joo SHIM; Yun-Seok CHOI; Woo-Seung SHIN; Jong-Min LEE; Chul-Soo PARK; Ho-Joong YOUN; Wook-Sung CHUNG; Jae-Hyung KIM.
Korean Circulation Journal ; : 370-376, 2010.
Artículo en Inglés | WPRIM | ID: wpr-9278

Documentos relacionados

  1. The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.
  2. [Research progress on the role of pentraxin 3 in polycystic ovary syndrome].
  3. [Change of serum levels of pentraxin-3 and syndecan-4 in children with chronic heart failure].
  4. BMP2 suppresses the production of pentraxin 3 in human endometrial stromal and decidual stromal cells.
  5. The Effects of Silencing PTX3 on the Proteome of Human Endothelial Cells.
  6. STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
  7. Plasma pentraxin-3 levels and its role in childhood obesity-Is it anti-inflammatory? A matched group study.
  8. Pentraxin 3 Inhibits Complement-driven Macrophage Activation to Restrain Granuloma Formation in Sarcoidosis.
  9. [The clinical significance of plasma PTX3 in patients with secondary hemophagocytic lymphohistiocytosis].
  10. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?